Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Androgen therapy in advanced carcinoma of the prostate.

× No keyword cloud information.

7 in total

1. THE USE OF P32 IN THE TREATMENT OF SEVERE PAIN FROM BONE METASTASES OF CARCINOMA OF THE PROSTATE.

Authors: J G SMART
Journal: Br J Urol Date: 1965-04

2. A clinical evaluation of radioactive pituitary implantation in the treatment of advanced carcinoma of the prostate.

Authors: J D FERGUSSON; D E PHILLIPS
Journal: Br J Urol Date: 1962-12

3. Steroid response to therapy in prostatic cancer.

Authors: F B BURT; R P FINNEY; W W SCOTT
Journal: J Urol Date: 1957-03 Impact factor: 7.450

4. Discussion of Dr. Huggins' paper: Control of cancers of man by endocrinological methods.

Authors: O H PEARSON
Journal: Cancer Res Date: 1957-06 Impact factor: 12.701

5. Inhibition of human mammary and prostatic cancers by adrenalectomy.

Authors: C HUGGINS; D M BERGENSTAL
Journal: Cancer Res Date: 1952-02 Impact factor: 12.701

6. Prostatic cancer; further investigation of hormonal relationships.

Authors: H BRENDLER; W E CHASE; W W SCOTT
Journal: Arch Surg Date: 1950-09

7. Testosterone potentiated 32P therapy in prostatic carcinoma.

Authors: R M Donati; H Ellis; N I Gallagher
Journal: Cancer Date: 1966-08 Impact factor: 6.860

7 in total

3 in total

1. Testosterone and prostate health: Have the paradigms truly shifted?

Authors: Alvaro Morales; D Robert Siemens
Journal: Can Urol Assoc J Date: 2020-08 Impact factor: 1.862

2. Adenocarcinoma of the prostate in perspective.

Authors: A W Bruce; D E Mahan
Journal: Can Med Assoc J Date: 1978-11-04 Impact factor: 8.262

3. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.

Authors: Feng Chen; Xiaodong Chen; Yu Ren; Guobin Weng; Peter C Keng; Yuhchyau Chen; Soo Ok Lee
Journal: J Mol Med (Berl) Date: 2019-06-11 Impact factor: 4.599

3 in total